Press "Enter" to skip to content

U.S. Increases Funding for Research Monkeys in the Aftermath of COVID

The U.S. government is investing substantially in breeding additional Monkeys at national institutions that keep primates for scientific research.

The objective is to compensate for an ongoing shortage of these animals, which worsened in 2020 when scientists tested a slew of COVID-19 vaccines and therapies on primates before beginning human trials.

The US NIH (National Health Institutes) has committed around US$ 29 million over the previous two years for house refurbishment, outdoor building, and other infrastructure enhancements at the U.S. National Primate Research Centers (NPRCs), which they finance.

By October, the company expects to spend an additional $7.5 million. And President of the U.S. Joe Biden suggested even more: noting the pandemic, the NPRCs’ request for the budgetary year 2022 recommends a 27% increase in spending. This would contribute $30 million for the centers if approved by Congress.

James Anderson, director of NIH Program Coordination, Planning and Strategic Initiative in Bethesda, Maryland, states, “We have invested in the development of levels and future plans. “We have done so. “What if [a pandemic] occurs again in three years with another virus? For that we want to be ready.”

U.S. scientists employ various medical problems, including infectious disorders, mostly non-human primates, most often rhesus macaques (Macaca mulatta).

Genetically and physiologically comparable to humans, Monkeys models can be used to conduct testing and tests before human tests or when human tests cannot be conducted. According to the U.S. government, in 2019, U.S. scientific researchers employed 68,257 non-human primates.

Be First to Comment

Leave a Reply

Your email address will not be published.